Drug retailer Rite Aid's revenue misses estimates

April 12 (Reuters) - Drug retailer Rite Aid, which is being bought by U.S. grocer Albertsons Cos Inc, posted smaller-than-expected fourth-quarter revenue, hurt by a decline in commercial business and prescription volumes.

Revenue fell to $5.39 billion from $5.9 billion.

Analysts had expected revenue of $5.57 billion, according to Thomson Reuters I/B/E/S. (Reporting by Vibhuti Sharma in Bengaluru; Editing by Sriraj Kalluvila)